Результати пошуку - Nicholas Butowski

Уточнити результати
  1. 1
    Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)

    Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis) за авторством Eduardo Rodriguez Almaraz, Nicholas Butowski

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Recent Advances in Therapy for Glioblastoma

    Recent Advances in Therapy for Glioblastoma за авторством Jennifer Clarke, Nicholas Butowski, Susan M. Chang

    Опубліковано 2010
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Treatment options for recurrent high-grade gliomas

    Treatment options for recurrent high-grade gliomas за авторством Harjus Birk, Seunggu J. Han, Nicholas Butowski

    Опубліковано 2016
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  4. 4
    A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

    A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM] за авторством David R. Gibson, Anh Huan Vo, Hannah Lambing, Prithanjan Bhattacharya, Peggy Tahir, Farid Chehab, Nicholas Butowski

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma за авторством Mei‐Yin C. Polley, Kathleen R. Lamborn, Susan M. Chang, Nicholas Butowski, Jennifer Clarke, Michael D. Prados

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

    Mouse models of glioblastoma for the evaluation of novel therapeutic strategies за авторством Alexander F. Haddad, Jacob S. Young, Dominic Amara, Mitchel S. Berger, David R. Raleigh, Manish K. Aghi, Nicholas Butowski

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  7. 7
    MRI Features and <i>IDH</i> Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis

    MRI Features and <i>IDH</i> Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis за авторством Javier Villanueva-Meyer, Matthew D. Wood, Byung Se Choi, Marc C. Mabray, Nicholas Butowski, Tarık Tihan, Soonmee Cha

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma

    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma за авторством Seunggu J. Han, Caleb Rutledge, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael D. Prados, Jennie Taylor, Mitchel S. Berger, Nicholas Butowski

    Опубліковано 2015
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma

    Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma за авторством Mario E. Lacouture, Mary E. Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong

    Опубліковано 2014
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma за авторством Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer Clarke, Michael D. Prados, Shannon Chang, Mitchel S. Berger, Annissa DeSilva, Nicholas Butowski

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma

    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma за авторством Jennifer Clarke, Annette M. Molinaro, Joanna J. Phillips, Nicholas Butowski, Shannon Chang, Arie Perry, J Costello, Annissa DeSilva, Jane Rabbitt, Michael D. Prados

    Опубліковано 2014
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma

    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma за авторством Edward Pan, Jeffrey G. Supko, Thomas Kaley, Nicholas Butowski, Timothy F. Cloughesy, Jinkyu Jung, Serena Desideri, Stuart A. Grossman, Xiaobu Ye, Deric M. Park

    Опубліковано 2016
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  13. 13
    Quality of life in low-grade glioma patients receiving temozolomide

    Quality of life in low-grade glioma patients receiving temozolomide за авторством Raymond Liu, Karla Solheim, Mei‐Yin C. Polley, Kathleen R. Lamborn, Margaretta Page, Anne Fedoroff, Jane Rabbitt, Nicholas Butowski, Michael D. Prados, Susan M. Chang

    Опубліковано 2008
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

    Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 за авторством Antonio Omuro, David A. Reardon, John H. Sampson, Joachim M. Baehring, Solmaz Sahebjam, Timothy F. Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowski, Michael Lim

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)

    Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) за авторством Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Yvonne Kew, Robert Cavaliere, John L. Villano, Daniela A. Bota, Jeremy Rudnick, Ashley Sumrall, Jay‐Jiguang Zhu, Nicholas Butowski

    Опубліковано 2014
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  16. 16
    A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)

    A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) за авторством Nicholas Butowski, Susan M. Chang, Larry Junck, Lisa M. DeAngelis, Lauren E. Abrey, Karen Fink, Tim Cloughesy, Kathleen R. Lamborn, Andres Μ. Salazar, Michael D. Prados

    Опубліковано 2008
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  17. 17
    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma

    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma за авторством Kazim Narsinh, Karishma Kumar, Krystof Bankiewicz, Alastair J. Martin, Mitchel S. Berger, Jennifer Clarke, Jennie Taylor, Nancy Ann Oberheim Bush, Annette M. Molinaro, Manish K. Aghi, Nicholas Butowski

    Опубліковано 2025
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  18. 18
    Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1

    Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1 за авторством Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang, Eric Burton, Nicholas Butowski, Mary Malec, A. Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley

    Опубліковано 2006
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  19. 19
    Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma

    Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma за авторством Susan M. Chang, Sarah J. Nelson, Scott R. VandenBerg, Soonmee Cha, Michael D. Prados, Nicholas Butowski, Michael McDermott, Andrew T. Parsa, Manish K. Aghi, Jennifer Clarke, Mitchel S. Berger

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  20. 20
    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma

    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma за авторством Jennie Taylor, Mili Parikh, Joanna J. Phillips, C. David James, Annette M. Molinaro, Nicholas Butowski, Jennifer Clarke, Nancy Ann Oberheim-Bush, Susan M. Chang, Mitchel S. Berger, Michael D. Prados

    Опубліковано 2018
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: